Introduction: What is Tisotumab Vedotin?
Tisotumab vedotin is a targeted cancer therapy designed to treat specific types of cancer, particularly advanced or metastatic cervical cancer. It is an antibody-drug conjugate that combines a monoclonal antibody with a cytotoxic drug, allowing for a more precise attack on cancer cells while minimizing damage to healthy tissues.
Uses of Tisotumab Vedotin
Tisotumab vedotin is approved for adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.